Clinical Trial Update: Efficacy, Safety & Tolerability of Ciclesonide 200mcg Spray 4 Weeks Treatment for Intermittent & Persistent Rhinitis

View source ↗

Summary

Clinical trial update on the efficacy, safety, and tolerability of a 4-week regimen of ciclesonide nasal spray (200 mcg) for intermittent and persistent rhiniti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis

Drugs mentioned

• ciclesonide (ciclesonide)

Snippet

Sponsor: AstraZeneca | Conditions: Perennial Rhinitis, Seasonal Rhinitis | Status: COMPLETED